Quarterly report pursuant to Section 13 or 15(d)

Equity Transaction - Schedule of Warrants Outstanding (Details)

v3.8.0.1
Equity Transaction - Schedule of Warrants Outstanding (Details)
 3 Months Ended
Mar. 31, 2018
USD ($)
$ / shares
shares
Weighted average exercise price granted | $ / shares $ 0.17
Warrants [Member]  
Number of Warrants outstanding beginning balance | shares 28,436,413
Number of Warrants granted | shares 3,000,000
Number of Warrants forfeited | shares (48,000)
Number of Warrants exercised | shares (1,281,000)
Number of Warrants outstanding ending balance | shares 30,107,413
Number of Warrants vested | shares 30,107,413
Number of Warrants exercisable | shares 30,107,413
Weighted average exercise price outstanding beginning balance | $ / shares $ 0.13
Weighted average exercise price granted | $ / shares 0.21
Weighted average exercise price forfeited | $ / shares 0.10
Weighted average exercise price exercised | $ / shares 0.17
Weighted average exercise price outstanding ending balance | $ / shares $ 0.14
Weighted average remaining contractual term outstanding 2 years 9 months 14 days
Weighted average remaining contractual term outstanding 3 years 1 month 24 days
Aggregate intrinsic value outstanding beginning balance | $
Aggregate intrinsic value granted | $
Aggregate intrinsic value exercised | $
Aggregate intrinsic value forfeited | $
Aggregate intrinsic value outstanding ending balance | $ 39,553,468
Aggregate intrinsic value vested | $ 39,553,468
Aggregate intrinsic value exercisable | $ $ 39,553,468